Synthetic Strategies for 14C Labelling of Drug Molecules
This presentation was given at Synthesis of Bioactive Molecules VI Symposium and focuses on carbon-14 introduction and synthetic strategies towards labelling potential drug molecules.
Speaker: Dr Sean L Kitson, Investigator (Radiochemistry) – Almac
- This lecture will focus on a brief introduction to ‘what is’ carbon-14
- Then leading onto some synthetic strategies towards labelling potential drug molecules with carbon-14
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.